Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint Inhibitors

Clinical trial NCT04751396 · RECRUITING

Trial details

NCT number: NCT04751396
Sponsor: M.D. Anderson Cancer Center
Status: RECRUITING
Study type: OBSERVATIONAL

Ankylosing Spondylitis Autoimmune Disease Crohn Disease Enteropathic Arthritis Enteropathic Spondylitis Inflammatory Bowel Disease Melanoma Psoriasis Psoriatic Arthritis Reactive Arthritis Rheumatoid Arthritis Systemic Lupus Erythematosus

Start date: 2022-04-20
Primary completion: 2027-02-02
Enrollment: 125

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.